Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. 28 April 2020. Peter Hatchett.

Executive Summary

The World Health Organization has launched a global push to speed development of diagnostics, vaccines and treatments that will help tackle the coronavirus pandemic. Here’s how Peter Hatchett, chief executive of the Coalition for Epidemic Preparedness Innovations (CEPI), explains the project’s benefits. 

“Everyone must have access to the tools and countermeasures – including vaccines – that we will develop through the [Access to COVID-19 Tools (ACT)] Accelerator. By bringing together the collective strengths, resources and expertise of the institutions that will contribute to the ACT Accelerator we can end this pandemic together.” – Peter Hatchett, chief executive, CEPI

Click here for a free trial of Medtech Insight

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT126655

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel